This Ferring-organised Meet-The-Expert symposium at the European Society of Medical Oncology (ESMO) 2019 meeting aimed to discuss new treatment modalities in the management of high-risk, non-muscle invasive bladder cancer (NMIBC).
In this issue
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given